Clinical Study
The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency
Table 1
Demographic and baseline characteristics.
| | IBD CD
() | IBD UC
() | Non-IBD
() | Total
() |
| | n (%) | | Gender | | | | | | Female | 46 (56.1) | 34 (50.7) | 93 (69.9) | 173 (61.3) | | Male | 36 (43.9) | 33 (49.3) | 40 (30.1) | 109 (38.7) | | Anaemica patients | () | () | () | () | | | 56b (68.3) | 44b (65.7) | 98 (74.2) | 198 (70.5) | | Patients with Hb < 10 g/dL | () | () | () | () | | | 14 (17.1) | 11 (16.4) | 41 (31.1) | 66 (23.5) | | Mean (SD) | | Age, years | () | () | () | () | | | 42.2 (16.2) | 41.1 (15.9) | 54.3 (18.6) | 47.6 (18.4) | | Weight, kg | () | () | () | () | | | 73.1 (17.3) | 76.4 (15.4) | 74.6 (16.4) | 74.6 (16.4) | | Hb, g/dL | () | () | () | () | | | 11.6 (1.7) | 11.5 (1.7) | 10.9 (1.9) | 11.3 (1.8) | | TSAT, % | () | () | () | () | | | 9.9 (7.1) | 9.4 (6.5) | 10.3 (7.3) | 9.9 (7.0) | | Ferritin, μg/L | () | () | () | () | | | 34.3 (59.8) | 28.3 (59.1) | 23.9 (84.9) | 27.9 (72.4) | | Median (IQR)c | 11.0 (6.2–27) | 11.0 (7.0–21) | 9.0 (5.6–16) | 10.0 (6.0–20) |
|
|
aHb < 13 g/dL (men) and Hb < 12 g/dL (women). bMean (SD) Hb in IBD patients 10.8 (1.4) g/dL and mean (SD) weight 75.4 (17.4) kg. cMedian is presented for data not normally distributed. CD: Crohn’s disease; Hb: haemoglobin; IBD: inflammatory bowel disease; IQR: interquartile range; SD: standard deviation; TSAT: transferrin saturation; UC: ulcerative colitis.
|
